Background -Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver injury around the world. It is associated with metabolic syndrome and cardiovascular diseases. Objective -To evaluate the frequency and relevance of NAFLD in patients with coronary artery disease (CAD). Methods -Patients from a Brazil Northeast area, who underwent elective coronary angiography (CAG) from 2009 to 2010 were included. All of them had suspicion of CAD. Criteria to CAD: presence of obstructive lesions in the epicardial coronary arteries, or in their major branches. NAFLD criteria: presence of hepatic steatosis on ultrasound; exclusion of other liver diseases; ethanol intake ≤ 20g/day. Statistics analysis included Independent t-test, Mann-Whitney and Pearson's chi-squared test. Multivariate regression analysis measured the relationship between the risk factors and the concomitant presence of CAD and NAFLD. Results -A total of 244 patients were evaluated: 63.5% had CAD and 42.2% had NAFLD. NAFLD was observed in 43.9% of the CAD patients. The regression analysis showed that the relationship between CAD and NAFLD was positively correlated with HOMA-IR ≥3.0 or insulin resistance and overweight/obesity. Conclusion -NAFLD was frequent among CAD patients; insulin resistance and overweight/obesity were the most relevant risk factors related to the association NAFLD and CAD. The results suggest that patients with CAD should be evaluated for NAFLD. HEADINGS -Fatty liver. Coronary artery disease. Cardiovascular diseases. Coronary angiography.
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) in general is an asymptomatic and under-diagnosed condition in patients with cardiovascular disease (CVD). Some parameters such as the presence of diabetes mellitus (DM), overweight, obesity, insulin resistance (IR), and liver enzyme abnormalities may suggest the existence of NAFLD (12, 22, 24) . Coronary artery disease (CAD) and they have been associated with the severity, progression and mortality in patients with NAFLD. Some studies have shown histological changes of NAFLD in association with CVD (7, 26) and the relevance of the relationship between NAFLD and CAD (1, 4, 5) . NAFLD also likely represents an independent risk factor for CAD and this is one of the most important causes of morbidity and mortality among these patients (6, 14, 27) .
The influence of ethnicity has been discussed in patients with NAFLD (8, 10) . The prevalence of NA-FLD is more elevated in Hispanics than in whites, and African Americans ranking as the ethnic group with the least prevalence of NAFLD (9) .
The present study evaluated the frequency and
The Ethics Committee on Human Research of Hospital Universitário Alcides Carneiro from Universidade Federal de Campina Grande, Brazil, approved the study. It was conducted according to the principles outlined in the Declaration of Helsinki (1964, revised 2008) .
Patients' evaluation
All patients answered a questionnaire, underwent physical examination and performed laboratory analysis and abdominal ultrasound (AUS).
The study parameters included gender, age, anthropometric measures, blood pressure levels, CAG indications, history of type 2 diabetes, arterial hypertension, dyslipidemia, acute myocardial infarction, alcohol intake, smoking habits and use of medications (including anti-diabetic, lipid-lowering, antihypertensive and hepatotoxic drugs: glucocorticoids, estrogens, amiodarone, carbamazepine, tamoxifen, and nonsteroidal anti-inflammatory).
Laboratory exams included HBsAg, anti-HCV, auto-antibodies (antinuclear, anti-smooth muscle, anti-mitochondria), total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides (TG), glucose, insulin, proteins, ferritin, transferrin saturation index, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), and alkaline phosphatase.
Measurements
Anthropometric measurements were evaluated according to the World Health Organization guidelines (15, 28) . Hypertension was diagnosed based on the VI Brazilian Guidelines on Hypertension (23) . DM was defined in accordance with the World Health Organization guidelines (3) . Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III report (18) . HOMA-IR ≥3.0 was considered insulin resistance (13, 16) .
Consumption of at least one cigarette a day in a period not less than 6 months defined regular smoking and former smokers, were those who smoked regularly up to 6 months before the examination (30) . A practitioner conducted face-toface interviews to determine daily alcohol intake, smoking habits and medication consumption.
All patients included in the study had selective left and right coronary angiography with the Judkins technique using a Pollux 100KW device (X-PRO Sistemas Ltda., Belo Horizonte, Minas Gerais, Brazil). The CAG were evaluated and recorded by at least two experienced cardiologists who had no information about the study.
The diagnosis of fatty liver was based on abdominal ultrasonography with a 3.5 MHz transducer using a Nemio 17 ultrasound machine (Toshiba Medical Systems Corporation, Otawara, Tochigi, Japan). The same experienced sonographer, who was not informed of the clinical history and CAG results, performed the abdominal ultrasound. Hepatic steatosis was diagnosed according to previous criteria (17, 19) .
CAD criteria on coronary angiography: stenotic lesion in the epicardial coronary arteries or their major branches.
NAFLD criteria: presence of hepatic steatosis on ultrasound; exclusion of other liver diseases; ethanol intake ≤20 g/day.
Statistical analysis
Statistical analysis included the independent t test and Mann-Whitney test for analysis of continuous variables, as appropriate. Categorical data were analyzed using Pearson's chi-square test. Multivariate regression analysis has measured the strength of the relationship between risk factors and the concomitant presence of CAD and NAFLD. Variables with P-value ≤0.15 in the univariate analysis were selected as the independent variables for the multivariate study. A selection process "stepwise" was applied to obtain a reduced model. All continuous variables were entered into the logistic regression model as continuous variables; they weren't converted into categorical data. Concomitant CAD and NAFLD was selected as dependent variable. All statistical methods were two-tailed, P values were calculated and the significance level was set to less than 0.05.
RESULTS
Two hundred forty four patients were included. The clinical characteristics of the sample are in Table 1 . CAG found 155 patients (63.5%) with CAD ([95%CI]: 57.1-69.6%). The prevalence of risk factors, such as male gender, type 2 diabetes and smoking, were significantly higher (P<0.05) in these patients than in the group without a CAD diagnosis ( Table 2) .
One hundred three (42.2%) patients had NAFLD (95%CI: 35.9-48.7%), and it was strongly associated with central obesity, diabetes and insulin resistance (IR), and significantly related to higher body mass index values, neck and waist circumferences ( Table 3 ). The association of NA-FLD with metabolic syndrome (P=0.024), lower levels of HDL-cholesterol (P=0.043), higher levels of TG (P=0.005), high levels of ALT (P=0.003), and ferritin (P=0.032) were significant.
The frequency of NAFLD in patients with a CAD was 43.9% (68/155). In univariate analysis (Table 4 ) several factors were statistically significant for the association between NA-FLD and CAD including central obesity, neck circumference, ferritin, overweight/obesity, and HOMA-IR ≥3.0 (P<0.001) Multivariate regression analysis was performed to measure the strength of the relationship between risk factors and the concomitant presence of CAD and NAFLD compared to CAD presence only. For the multivariate study, it was selected variables with P<0.15 in the univarieate analysis ( Table 4 ). The variables age, DM, neck circumference, central obesity, overweight/obesity, fasting insulin, HOMA ≥3.0, TG, HDL-cholesterol, and ferritin entered in the initial model. With these variables it was adjusted a multivariate logistic regression model. The model selected age, diabetes, central obesity, neck circumference, overweight/obesity, fasting insulin, HOMA ≥3.0, HDL-cholesterol, TG, and ferritin. A selection process "stepwise" was applied to obtain a reduced model. The adjusted model was given by HOMA ≥3.0 and overweight or obesity. The result of regression analysis showed that the possibility of concomitant occurrence of CAD and NAFLD was positively correlated with these variables ( Table 5 ). The positive predictive value found for HOMA ≥3.0 was 67.3%, while the negative predictive value was 67%. In relation to overweight or obesity, these values were 55.2% and 87.8%, respectively. of these individuals came from out clinics to perform elective coronary angiography with suspicion of CAD. The similar studies included patients with metabolic syndrome only (4) , admitted with acute coronary syndrome and AMI (1, 29) and hospitalized patients with CAD (25) . These cases, in general, have more severe CAD disease. The criteria for CAD used here was different from other studies, because any obstructive lesion in the epicardial coronary arteries or in their major branches were considered. This approach can help early diagnosis of CAD in patients with NAFLD. Taking into account that coronary occlusion and myocardial ischemia may frequently be due to mild or moderate lesion, the identification of such levels of obstruction in patients with NAFLD might be important for the risk stratification and therapeutic orientation. It could also help to reduce morbidity and mortality of these patients. However, others considered the stenosis of at least 50% in at least one major coronary artery to CAD diagnosis (5, 25, 29) , or stenosis of at least 50% in epicardial arteries or their major branches (1) , and two studies evaluated the association between NAFLD and CAD severity (4, 25) . In this sense, significant stenosis was defined as 70% or greater reduction in luminal diameter in any view compared with the nearest normal segment.
The patients' background and ethnicity should also be considered in the discussion. This study included patients with several ethnic descended who come from South America and the majority of others studies came from Asia. There they have others epidemiological factors, ethnicity and behaviors, that could have influenced the results. Asians, even those living in the West, seem to be more at risk for NAFLD than their Caucasian and African American counterparts. In addition, they develop NAFLD at a younger age, and NAFLD patients are more likely to be male (2) . These characteristics could contribute to the NAFLD and CAD association. Therefore, this study made possible to inform the scientific community, results observed in our population which has socioeconomic, ethnic and behavioral characteristics different from other populations previously studied. On the other hand, our results agree with the study published by Feitosa et al. (11) , which evaluated 2,756 European-American. In their study, no association was observed between fatty liver diagnosed by computed tomography and coronary heart disease.
In conclusion, this is the first study that involved patients from a Brazil Northeast area and that showed the relevance of NAFLD in patients with CAD. The regression analysis showed that insulin resistance, overweight or obesity are the most relevant risk factors for the possibility of concomitant occurrence of CAD and NAFLD in these patients, and the results suggested that NAFLD should be investigated in CAD patients with these characteristics, in order to reduce morbidity and mortality. 
DISCUSSION
Some studies have evaluated the association between NA-FLD and CAD diagnosed by coronary angiography (1, 4, 5, 25, 29) a gold standard method for diagnosis of coronary disease. However, most of them have evaluated the risk factors, and its relationship with the presence of CAD or NAFLD alone and the majority of the studies come from Asia.
The present study included a large series of patients submitted to coronary angiography, who come from an area of Northeast of Brazil which population has a low economic status and several ethnic descended, like Amerindians, Africans and Europeans.
These factors are relevant. Race and ethnicity can be predictive factors of liver diseases complications and response to treatment in patients with chronic liver disease. These ethnic differences should influence the prevalence and profile of NAFLD in South America and studies from some countries have shown the relevance of this liver disease in this continent (20, 21) .
The risk factors related to the presence of CAD in these Brazilian patients were male gender, smoking, type 2 diabetes, lower levels of HDL-cholesterol and a higher frequency of use of lipid-lowering drugs. NAFLD was associated with DM, insulin resistance, BMI, higher levels of triglycerides and waist circumference, lower HDL-cholesterol, obesity, and metabolic syndrome. Similar results were found in other studies regarding CAD and gender (1, 25, 29) , smoking, DM (1) , lower levels of HDL-cholesterol (1, 29) , and a higher frequency of use of lipid-lowering drugs (1) and NAFLD association with DM (25, 29) , BMI, higher levels of triglycerides and waist circumference, lower HDL-cholesterol levels (4, 25, 29) , obesity, and metabolic syndrome (25) .
This investigation did not observe association between NAFLD and age, arterial hypertension, gender, and CAD. These results are distinct from other studies especially regarding the absence of association between NAFLD and CAD (1, 4, 5, 25, 29) . The hypothesis for these findings are the different population, who was evaluated; the criteria of CAD diagnose; and the patients' precedence. The majority
